Chromos' ACE System is a versatile and potent biological engineering system based on proprietary artificial chromosome technology that facilitates the rapid engineering of stable high expressing production cell lines for the clinical and commercial manufacture of biopharmaceuticals.
The terms of agreement include the following: - Chromos will engineer cell lines specific for the expression of a proprietary monoclonal antibody for Pain Therapeutics using the ACE System.
- Pain Therapeutics has the right to use the cell lines for scale up and manufacture of the proprietary monoclonal antibody, following the cell line engineering phase of the agreement.
However, he financial details of the agreement were not disclosed.
Read the full report for more details.
Comment Preview